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Abstract: Background: Mobile health is a promising strategy aiming to anticipate and prevent the de-
terioration of health status in palliative cancer patients. A prerequisite for successful implementation of
this technology into clinical routine is a high level of usability and acceptance of devices. Objectives:
We aimed to evaluate feasibility as well as patients’ acceptance of remote monitoring using wearables in
palliative cancer patients. Methods: In this prospective single-center observational feasibility study, 30
cancer patients treated with palliative intent in an inpatient setting with an estimated life expectancy of
>8 weeks and <12 months were provided with a smartphone including a pre-installed “Activity Monitor-
ing” app and a sensor-equipped bracelet and monitored over a period of 12 weeks starting at discharge
from hospital. We report detailed feasibility and usability aspects and comment on patients’ acceptance
of the wearables. Results: Between February 2017 and May 2018 a total of 30 patients were included
in the study. From these, 25 participants (83%) completed the whole study period. On average, the
bracelet was worn on 53% and smartphone used on 85% of the study days. The completion rate of daily
digital questionnaires for subjective ratings (pain and distress scale) was 73%, and 28 patients were able
to handle the wearables and to operate the app without major problems. Use of the bracelet was low
during the night hours, with a wearing time of 1.7% of all night hours (8 p.m. to 8 a.m.). Conclusions:
Remote monitoring of health care status in palliative cancer patients with a limited life expectancy is
feasible and patients are able to handle the smartphone and the sensor-equipped bracelet. Feedback
towards use of this monitoring system was mostly positive.
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Abstract
Background: Mobile health is a promising strategy aiming 
to anticipate and prevent the deterioration of health status 
in palliative cancer patients. A prerequisite for successful im-
plementation of this technology into clinical routine is a high 
level of usability and acceptance of devices. Objectives: We 
aimed to evaluate feasibility as well as patients’ acceptance 
of remote monitoring using wearables in palliative cancer 
patients. Methods: In this prospective single-center obser-
vational feasibility study, 30 cancer patients treated with pal-
liative intent in an inpatient setting with an estimated life 
expectancy of > 8 weeks and < 12 months were provided 
with a smartphone including a pre-installed “Activity Moni-
toring” app and a sensor-equipped bracelet and monitored 
over a period of 12 weeks starting at discharge from hospital. 
We report detailed feasibility and usability aspects and com-
ment on patients’ acceptance of the wearables. Results: Be-
tween February 2017 and May 2018 a total of 30 patients 
were included in the study. From these, 25 participants (83%) 
completed the whole study period. On average, the bracelet 
was worn on 53% and smartphone used on 85% of the study 
days. The completion rate of daily digital questionnaires for 
subjective ratings (pain and distress scale) was 73%, and 28 
patients were able to handle the wearables and to operate 
the app without major problems. Use of the bracelet was low 
during the night hours, with a wearing time of 1.7% of all 
night hours (8 p.m. to 8 a.m.). Conclusions: Remote monitor-
ing of health care status in palliative cancer patients with a 
limited life expectancy is feasible and patients are able to 
handle the smartphone and the sensor-equipped bracelet. 
Feedback towards use of this monitoring system was mostly 
positive. © 2019 S. Karger AG, Basel
Introduction
Cancer patients in palliative care are a high-burdened 
patient population who experience several health prob-
lems and symptoms. Deterioration of health status is com-
mon. In consequence, emergency visits and the need for 
inpatient care to stabilize symptoms such as pain, dys-





emergency visits and readmissions in this patient group 
are deemed avoidable [4, 5]. Therefore, strategies to an-
ticipate and prevent the deterioration of health status are 
needed. However, continuous monitoring of patients in 
an outpatient setting is often not feasible due to lack of 
human resources, calling for novel and innovative ap-
proaches. Recent developments in wearables technology 
make them suitable for healthcare purposes. Mobile health 
technology has been explored in different diseases and pa-
tient groups [6–9] and the use of wearables including 
smartphones and sensor-equipped devices in medical re-
search is growing constantly. There is research activity in 
cancer patients using activity monitors, consisting mostly 
of a pedometer or accelerometer [10]. However, the use of 
wearables in healthcare is still in its early phase, and de-
spite evolving evidence in the field of mobile health tech-
nology in different patient groups, there is scarce knowl-
edge about the use of wearables in palliative cancer pa-
tients. Prospective trials are needed to assess the 
effectivity of wearables and their impact on clinical out-
come. A prerequisite for successful implementation of this 
technology into clinical routine is a high level of usability 
of devices to sustain their usage. There is increasing evi-
dence that usage of wearables and mobile applications to 
report symptoms in cancer patients in general is feasible 
[10, 11]. Palliative cancer patients experience more and 
worse symptoms than cancer patients treated in a curative 
setting and are therefore often considered too burdened 
to deal with a new technology [12]. Accordingly, evidence 
on mobile health technology in palliative cancer patients 
including knowledge on usability aspects is lacking. Only 
3 out of 41 trials in a review on wearable activity monitors 
in oncology included patients with metastatic cancer [10].
In this prospective observational study, we aimed to 
evaluate the feasibility as well as patients’ acceptance of re-
mote monitoring in an outpatient setting using wearables 
in palliative cancer patients. The hypothesis was that health 
monitoring by a smartphone and sensor-equipped arm 
bracelet is feasible in this severely ill patient group and en-
ables the prediction of a decline in health status. The results 
on mobile health features as predictive biomarkers will be 
reported elsewhere [unpubl. data]. Here, we report detailed 
usability aspects and patients’ acceptance of wearables.
Materials and Methods
Patient Cohort
This prospective observational study was conducted at the Uni-
versity Hospital Zurich. A more detailed research protocol has been 
described before [13]. Eligibility criteria were age > 18 years, pres-
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ence of a severe medical condition (incurable cancer with an esti-
mated life expectancy of > 8 weeks to < 12 months judged by a phy-
sician of the project team, severe cardiac disease with NYHA III–IV 
symptoms or severe pulmonary disease having a COPD GOLD III–
IV), performance status of ECOG ≤2 and/or KPS ≥50%, no rele-
vant cognitive impairment and good knowledge of the German lan-
guage. In addition, patients had to be able to handle a smartphone, 
which was briefly tested. After instructions on how to use and han-
dle the smartphone as well as the bracelet, patients had to pass a 
mini practical test, ensuring that they were able to handle the de-
vices. We aimed to include 30 patients being discharged from in-
patient care at the radiation oncology or specialized palliative care 
ward. The study was proposed to all eligible patients. All were asked 
to complete a questionnaire about their previous experience with 
electronic devices. Patients who refused participation in the study 
were asked about their reasons for declining.
Electronic Devices and the Active Monitoring App
Participating patients were provided with devices consisting of a 
smartphone Galaxy S5 mini, equipped with a prepaid SIM card, and 
the bracelet Everion® by Biovotion (Biovotion, Zurich, Switzerland). 
Patients also had the possibility to use their own smartphone (An-
droid smartphone). In this case, the “Activity Monitoring” app was 
installed on the patients’ smartphone. We chose the Biovotion brace-
let because of its official approval as a medical device in the USA (ISD 
890.5360) and in Europe (CE 0123), the broad range of parameters 
measured by the device and the possibility for storage of data outside 
of the companies’ cloud service. The bracelet was worn on the upper 
arm, fixed by an elastic belt. The size of the belt was fitted to the pa-
tients’ arm. A smartphone belt was optional.
The “Activity Monitoring” app has been designed and adapted 
specifically for the needs of palliative care patients. To evaluate and 
finalize the app’s user interface, an interview study including 12 
cancer patients was previously conducted and the results were im-
plemented [14, 15]. Variations in the font size and color of the in-
terface elements as well as different control elements (a button or a 
slider) were proposed. According to patients’ preferences, the app 
was designed with large numbers and a rather simple design to en-
sure easier handling (Fig. 1). The app consists of two parts: a patient 
interface providing digital questionnaires to rate the subjective pain 
and distress on a visual analog scale (VAS) and a sensor logging 
module for recording and transmitting signals from smartphone 
sensors. Additionally, the app includes an interface to the brace- 
let – for management of Bluetooth connection and to request, re-
ceive, and record sensor signals of the bracelet and transmit these 
signals encrypted to a secured server at the Swiss Federal Institute 
of Technology (ETH Zurich). Sensitive data, such as GPS, were an-
onymized. The app additionally provided and displayed informa-
tion about the current heart rate and daily step count that was mea-
sured by the smartphone sensor (Fig. 2). Patients without internet 
connection at home were provided with a mobile Wi-Fi hotspot.
Study Procedures and Evaluation of Usability Aspects
The study phase of 12 weeks started at discharge from hospital. 
Patients were asked to wear the devices as often and long as possible 
– ideally all day long including during night hours – except for the 
time needed to charge the battery. During the first week at home, a 
study member visited the patient to ensure the correct deployment 
of the device, mainly configuration of Wi-Fi for data transmission. 
Patients staying first in a rehabilitation unit after discharge from hos-
pital were visited when returning home. Patients going on vacation 
during the study period paused tracking during their holiday and 
resumed after returning home. Subjective ratings of symptoms were 
ba
Fig. 2. Illustration of the start screen (a) and display of heart rate 
and daily step count (b).
12 weeks of:
 Remote monitoring
 Evaluation of daily (VAS for pain + distress) and
 weekly (EORTC QLQ-C30) subjective symptoms
End evaluation:
 EORTC QLQ-C30 and ESAS
 Semiquantitative questionnaire about patients‘
experiences in the handling and usage of the devices
Eligible patients:
 Metastatic cancer/severe cardiac or pulmonary illness
 ≥18 years
 Life expectancy <12 months and >8 weeks
 KI ≥50%/ECOG ≤2/NYHA II–III/GOLD 3–4 
 No relevant cognitive impairment
 Passing practical mini test
Consenting patients received:
 Everion® bracelet
 Smartphone or Acitvity Monitoring app on 























































evaluated 1 day prior to discharge using the EORTC-QLQ-C30. This 
was repeated weekly during a phone call. The Edmonton Symptom 
Assessment System (ESAS) was filled out 1 day before discharge and 
at the end of the study period. VAS for pain and distress were rated 
daily in the app. A vibration alarm reminded the patients to fill out 
the VAS. At the time of vibration, the questionnaire showed up au-
tomatically on the screen. In case it was not answered immediately, 
the alarm was repeated up to five times every 5 min. The time win-
dow the questionnaire showed up was randomized between 8 a.m. 
and 8 p.m., but it was also possible to adapt the time window to pa-
tients’ wishes (for example between 10 a.m. and 12 a.m.). Patients 
could also start the VAS on their own if they felt like and were free 
to answer it multiple times a day. If a score of ≥5 for distress was 
reached within a week, the second part of the distress questionnaire, 
evaluating reasons for this distress, was filled out during the weekly 
phone call. During the weekly interviews patients reported any prob-
lems with charging or operating the wearables. Additionally, they 
were asked if they had difficulties with the “Activity Monitoring” 
app. A more detailed semi-structured interview on usability aspects 
containing nine open-ended questions was performed at the study 
end (see Appendix Fig. A1 and A2 for details of the questions asked). 
An overview of study procedures is shown in Figure 3.
Data Analysis
Results obtained in this prospective trial concerning feasibility 
and usability aspects are of a qualitative nature and accordingly 
evaluated and presented [16]. Qualitative questionnaire responses 
of the weekly and final interview were analyzed manually and the 
most prevalent and significant comments and experiences sum-




Between February 2017 and February 2018, a total of 68 
patients fulfilled all the eligibility criteria. Of these, 31 pa-
tients consented to participate and were included. One pa-
tient died only a few days after discharge before any usage 
of wearables, thus no data are available for this patient. 
Nine of the 30 patients included in the analysis were female 
and 21 were male. The median age was 64 years (range 39–
85). Table 1 provides more details about demographic data 
on participants and eligible patients not willing to partici-
pate. None of the patient characteristics differed signifi-
cantly between study participants and eligible non-partici-
pants. Information on previous experience with electronic 
devices as well as reasons for rejection of study participa-
tion are reported in a not yet published paper, together with 
the results on the predictive ability of remote monitoring.
Completeness of Data Collection
Twenty-five out of 30 patients (83%) completed the 
full study period of 12 weeks. Two out of 5 dropouts were 
due to technical problems with Bluetooth connection; in 
1 of these cases the Bluetooth module in the smartphone 
was defect. The other dropouts were health related: all 3 
patients had to quit the study because of severe deteriora-






Age, years 64 (53.00–71.00) 69 (63.00–73.75) 0.136 (0.329)
Sex
Male 22 (71.0) 17 (60.7) 0.425 (0.217)
Female 9 (29.0) 11 (39.3)
ICD code
C34 (lung cancer) 9 (29.0) 11 (39.3)
C71 (brain tumor) 6 (19.4) 3 (10.7) 0.562 (1.339)
C50 (breast cancer) 3 (9.7) 2 (7.1)
Other 13 (42) 11 (43)
Age-adjusted CCI
5 (4–7) 6 (4–8) 0.323 (0.276)
ECOG
0–1 18 (58.1) 13 (48.1) 0.534 (0.317)
2 13 (41.9) 14 (51.9)
KPS
80–100 13 (52.0) 7 (31.7) 0.300 (0.736)
50–70 12 (48.0) 15 (68.2)
Values are the median (range) or n (%). CCI, Charlson Comorbidity Index; ECOG, Eastern Co-Operative 
Oncology Group; KPS, Karnofsky Performance Status.




tion of health status with consecutive death shortly there-
after. The smartphone was worn on average for 85% (SD 
19.4) and the bracelet for 53% (SD 28.0) of all study days. 
Eighteen patients (60%) wore the bracelet for more than 
50% of the study days. Concerning the smartphone usage 
rate, the number of patients wearing it for more than 50% 
of the days was higher (28 patients; 93.3%). Twenty-three 
of the 30 patients (76.7%) carried the smartphone with 
them for more than 80% of all study days. On those days, 
when the wearables were put on, the bracelet was worn 
for 63% (SD 16.8) and the smartphone for 50% (SD 24.2) 
of the day time (considered as between 8 a.m. and 8 p.m.). 
Patients were also told to wear the bracelet during night 
hours if they were motivated to do so. Seven patients 
(23.3%) never put the bracelet on during the night and, 
overall, patients wore the bracelet for 1.7% of all night 
hours (considered as between 8 p.m. and 8 a.m.). The dig-
ital questionnaires (pain VAS and distress thermometer) 
were answered on 73% (SD 22.8) of the days. It is note-
worthy that some patients answered the digital question-
naires more than the requested once per day. In total, 13 
out of 30 patients answered the questionnaire on average 
> 1.5 times per day. The maximal answering rate was 5.7 
times per day in 1 patient – in the final interview the pa-
tient explained that he wanted to report every change in 
subjective symptoms. The proportion of patients carry-
ing the wearables, usage time, and rate of patients answer-
ing the digital questionnaires did not drop during the 
study period. Weekly interviews on device handling were 
answered in 83% of all weeks (all patients in total consid-
ered). One patient was excluded from this analysis be-
cause he experienced severe hoarseness and could there-
fore hardly speak on the phone. He was one of the patients 
who quit the study due to health deterioration. Final in-
terviews were completed by 26 out of 30 participants 
(86.7%).
Feedback Concerning the Handling of Wearables and 
the “Activity Monitoring” App
Nine out of the 30 patients (30%) did not report any 
problems during the whole study period. Twenty-one pa-
tients (70%) reported difficulty at least once with either 
one of the wearables or the app. However, in most cases, 
problems related not to the handling of the device or app 
itself, but rather to technical problems occurring occa-
sionally during the operation of the electronic devices, 
like a crash of the app or the touchscreen not responding, 
with both events demanding a restart. A secondary issue 
was mainly that the step count or the heart rate were not 
displayed correctly (according to the judgement of par-
ticipants), or not at all. Furthermore, the sensor occasion-
ally lost connection to the smartphone and had to be re-
connected “manually.”
Only 2 study participants (6.7%) had problems han-
dling the wearables from the outset of the study. Both 
participants had no previous experience with smart-
phones or activity tracking watches. One of the 2 patients 
who struggled with the smartphone and bracelet was aged 
85 years, the oldest participant in the study. Both patients 
had problems operating the devices and app, such as for-
getting how to make a phone call or write a message. The 
85-year-old patient filled out the digital questionnaires 
on only 11.8% of all study days, and wore the bracelet on 
10.5% and carried the smartphone on 51.3% of the days. 
She explained that she is forgetful in addition to having 
problems operating the app. The other patient who expe-
rienced difficulties handling the wearables and the app 
was a 67-year-old participant without any memory issues. 
On several occasions she requested support from the 
study team, who instructed her on how to use the wear-
ables and the app, after which she was able to learn the 
procedures. In contrast to the other patients she had high 
completion rates, filling out the questionnaires, wearing 
the bracelet, and carrying the smartphone on 86.2, 92.6, 
and 95.7% of all study days, respectively.
Concerning usage of the “Activity Monitoring” app, 
21 patients (70%) stated during the whole period that 
handling was easy. Only 9 of the 30 patients (30%) stated 
in at least one of the weekly interviews that usage of the 
app needed some customization or was even cumber-
some. However, 7 of these 9 patients rated in only one of 
all of their interviews that they need to familiarize them-
selves with handling of the app, mainly during one of the 
first weeks of the study, and in the remaining interviews 
reported handling to be easy. Therefore, overall, the ma-
jority of the participants (28 out of 30 patients) were able 
to operate the app easily.
Feedback on the Comfort of the Bracelet
As reported above, usage of the bracelet during night 
hours was sparse. The main reason for not wearing the 
bracelet was using night hours to charge the bracelet, as 
reported by 21 patients. Only 6 participants specified in 
any of the weekly interviews that it felt uncomfortable to 
wear the bracelet while sleeping. Another 3 patients re-
ported that it was uncomfortable to wear the bracelet 
when the weather was too hot – the elastic belt led to an-
noying sweating. All these patients participated during the 
summer, commencing in June 2017. Six patients reported 





the patients then tried to wear it on their leg and rated this 
as very convenient. Another patient continued to have 
problems with an uncomfortable elastic belt even after ex-
changing to another one – he had a slightly larger upper 
arm and experienced that the band rolled up. Two patients 
would have favored wearing the bracelet on their wrist.
General Perception of the Study and Comments on 
Devices, Pitfalls, and Suggestions for Improvements
In general, 20 patients stated a positive overall rating 
concerning the study. Only 1 patient reported to be happy 
that the study was over. Others did not state if they rated 
the study rather positively or negatively, but gave direct an-
swers to the questions: “What is your general impression 
on the study?” and “What went well and what was diffi-
cult?” Here are some examples: “The devices are quite eye-
catching,” “The biggest problem was that the battery of the 
smartphone switched to energy-saving mode due to fast 
consumption despite normal usage,” and “It is cumber-
some to operate even more devices.” The last quote was 
from a patient who had to walk on crutches and reported 
difficulties in putting the bracelet on and wearing the 
smartphone on their body. Feedback from others in contact 
with the subjects was either positive or people expressed 
curiosity, but no negative comments were given. One par-
ticipant discussed the issue of data security with friends and 
relatives. Three patients declared spontaneously that they 
would like to see all their data collected by the wearables. 
Nine participants in total stated that they had to recharge 
the battery of the wearables (either smartphone or bracelet 
or both) very often. Four patients stated that having no dis-
play of the battery load of the bracelet was cumbersome and 
would therefore like to see the percentage of battery charge.
Concerning recommendations for future applications 
and developments, comments were mainly related to as-
pects perceived as cumbersome and already stated in the 
first part of the interview (prolong battery life of wear-
ables, display of battery life of the bracelet, and 2 patients 
commented that they would suggest a bracelet for the 
wrist). Three patients suggested that the data captured 
during the study should be discussed with the patients: 
“Feedback should be given to the patient if there is a wor-
risome trend in vital signs.”
Discussion
The overall aim of remote monitoring using mobile 
health technology is to advance the care of palliative 
cancer patients. Wearables could lead to a reduction of 
re-admissions or emergency visits by anticipating a 
health status deterioration. For successful implementa-
tion of electronic devices into the clinical routine, it is 
of utmost importance that patients are able to cope with 
these devices. We could show that continuous health 
monitoring using mobile technology in palliative can-
cer patients is feasible and accepted by the majority of 
patients. Patients were able to use and handle the smart-
phone as well as the bracelet over a long period of 12 
weeks. Out of 30 patients included, 28 reported no ma-
jor issues with handling and were able to handle the de-
vices and the app during the whole study period. Feed-
back on remote monitoring using the wearables was 
mostly positive.
This finding is of importance as so far there are lim-
ited data available on the feasibility of use of mobile 
technology in palliative oncological patients. However, 
this is a premise for successful implementation of such 
a system. Most data are on the usage of remote commu-
nication systems or electronic symptom-reporting sys-
tems, which are feasible in palliative care patients [17–
19]. McCall et al. [20] have proven that oncological pa-
tients receiving palliative care in their homes are able to 
report their symptoms electronically daily over a period 
of 30 days. However, activity and vital signs monitors 
are so far not widely investigated in this patient group, 
and existing data are mostly on accelerometers and pe-
dometers [21, 22]. Therefore, evidence that handling of 
two devices – a smartphone with the pre-installed app 
as well as a sensor-equipped bracelet measuring a lot of 
different features – is feasible, provides important infor-
mation.
Our results are in line with the limited data already 
existing on this topic. Low et al. [23] investigated a mon-
itoring system consisting of an android with the AWARE 
framework (an application for capturing data) installed 
on it, as well as a Fitbit. Fourteen patients undergoing 
chemotherapy for gastrointestinal cancer participated 
for a mean duration of 21.07 days. The authors con-
cluded the use of such a monitoring system being fea-
sible in these patients. However, no details on usability 
aspects and acceptance were given. Wright et al. [24] 
evaluated an accelerometer-based monitoring system 
over a period of 30 days in 10 gynecological patients un-
dergoing palliative chemotherapy focusing on feasibil-
ity, acceptability, and perceived effectiveness. These pa-
tients used a smartphone with the Beiwe research plat-
form (also a tool for the collection of data) on it and two 
accelerometers. Adherence rates of 70% to smartphone 
surveys and 90% to wearable accelerometers were re-




ported. It is notable that adherence was fulfilled if sur-
veys or accelerometers were operated a minimum of 4 
days per week, which is different to our study where we 
counted each day and provided the number of days pa-
tients wore the wearables in relation to the total study 
duration. Nine out of the 10 patients did not regret hav-
ing participated in the study and would recommend the 
application to a friend.
To our knowledge there is no other trial reporting the 
feasibility of mobile health technology consisting of two 
wearables over such a long period and in such a distinct 
patient cohort with initially defined concise inclusion cri-
teria concerning life expectancy and health status. Pa-
tients were able to participate for the full study period of 
12 weeks in most cases (25 out of 30 patients). The pro-
portion of days on which wearables were worn at all was 
much higher for the smartphone compared to the brace-
let, at 85% (SD 19.4) and 53% (SD 28.0) of all study days, 
respectively. Conversely, the wearing time per day was 
higher for the bracelet compared to the smartphone, at 
63% (SD 16.8) and 50% (SD 24.2), respectively. This find-
ing is not surprising: patients did take the smartphone 
with them often; however, when at home they did not 
wear it on their body but generally left it in a certain place, 
for example on the table while they were in the living 
room. Once the bracelet had been put on, the patients left 
it on until they needed to remove it. The usage rate and 
time during night hours was limited. Adherence was sta-
ble over the length of the study, indicating that partici-
pants who tolerate monitoring from the start will con-
tinue to do so in the future.
Our feasibility study has some limitations. First of all, 
the small number of patients precluded a thorough 
analysis of the patient factors predictive of compliance 
and the successful use of wearables. Furthermore, we 
did not evaluate reasons for the acceptance of wearables 
or patients’ expectations on the impact of such devices. 
El Shafie et al. [25] performed a survey evaluating the 
acceptance and expectations of use of a mobile app in 
breast and prostate cancer patients undergoing radia-
tion therapy. A large proportion (>  70% of patients) 
showed strong interest in using a mobile app during ra-
diotherapy and clinical follow-up. Most commonly, ap-
pointment scheduling was reported as a possible useful 
mobile tool. However, the surveyed patient cohort was 
distinct from the patient population in our study. Only 
15.5% of them received a palliative treatment, whereas 
the vast majority underwent treatment in a curative set-
ting. Not only acceptance by patients, but also by health 
care providers, is a requirement for the broad imple-
mentation of electronic devices for remote monitoring 
into a clinical routine. We did not analyze the opinion 
of medical staff on the use of the wearables. Kessel et al. 
[26] performed a survey investigating the attitude of 
health care professionals, working in the field of oncol-
ogy, towards mobile health. Overall, of 108 profession-
als 88.9% considered telemedicine to be a useful tool. 
The patient group was not further specified within the 
survey and thus results applied for oncological patients 
in general. Cox et al. [12] interviewed physicians work-
ing with lung cancer patients in a palliative care setting 
and analyzed their perceptions of e-technology for 
symptom assessment. They regarded cancer patients 
treated in a palliative setting as generally too old and too 
burdened to deal with a new technology. This is in con-
trast to the results of our feasibility study.
In conclusion, here we provide evidence that remote 
monitoring of health status in palliative cancer patients 
with a limited life expectancy is feasible and patients are 
able to handle the smartphone and the sensor-equipped 
bracelet as long as their condition is not worsening in a 
very rapid way. Monitoring during night hours was not 
achieved. Given the possibilities of remote monitoring 
and hope for improvement of patient care by preventing 
re-admissions, further research in this area is warranted. 
In doing so, the mobile health community should not 
only focus on the development of mobile health apps and 
devices and research on algorithms for outcome predic-
tion, but should also put effort into exploring and defin-
ing legal aspects (data security and privacy) and prove 
the cost-effectiveness of digital health tools [27]. Our re-
sults support the effort put into mobile health technology 
in palliative cancer patients and provide impetus to 
maintaining the research focus not only on patient-re-
ported outcomes, which were proven to have a clinical 
significance, but also investigate the impact of activity 
and vital signs monitoring in palliative cancer patients 
[28, 29].
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